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A B S T R A C T
Background: Allergic rhinitis is a chronic and recurrent nasal condition. It is often neglected in children with late
presentation. This study aimed at determining the prevalence, sociodemographic features, comorbid illnesses,
complications and quality of life in children with allergic rhinitis in the study institution.
Materials and methods: This is a prospective hospital based study of children with allergic rhinitis in Ekiti state
university teaching hospital, Ado Ekiti. The study was carried out in ENT department over a period of two years
(between June 2015 to May 2017). Informed consent was obtained from the parents/guardian/patients and
consented patients were enrolled into the study. Data were obtained by pretested interviewers assisted ques-
tionnaire. Details of their history, physical examination and investigations were carried out and ﬁndings were
documented. All data obtained were descriptively analysed using SPSS version 18.0 and presented in simple
tables and charts. Ethical clearance was sought for and obtained from the ethical committee of the hospital.
Results: A total of 4341 patients were seen out of which 265 were children with allergic rhinitis. Prevalence of
allergic rhinitis in children in this study was 6.1%. There were 63.0% males with male to female ratio of 2:1.
Allergic rhinitis was peaked at preschool age group (1–5 years) accounted for 47.9%.
A total of 42.3% participants were living in urban setting while 57.7% were from rural setting. Majorities
(40.4%) of the patients were in nursery and parent's major occupation was mainly farming in 27.2%.
There was positive family history of allergy in 54.7% patients. Perennial allergic rhinitis were noted in 63.8%
patients while seasonal allergic rhinitis were noted in 36.2% patients. Major form of allergens was inhalant
81.8% and the least form of allergen was ingestant 5.7%.
The commonest identiﬁed trigger factors among the study population were as follows: dust, cold weather and
smoke which were accounted for 59.6%, 37.4% and 18.9% of the study patients respectively. Other noted
triggering factors were soap and perfume which accounted for 4.2% and 1.1% respectively.
Major associated comorbid illnesses among the patients were tonsils hypertrophy, adenoid hypertrophy and
inferior turbinate hypertrophy which accounted for 55.5%, 46.4% and 40.4% respectively. Clinical presentations
of allergic rhinitis in this study were mainly 75.8% nasal blockage, 65.3% runny nose and 8.5% recurrent
sneezing.
Commonest complications of allergic rhinitis were 35.1% pharyngitis, 32.1% otitis media and 28.3% head-
ache.
Treatment of allergic rhinitis leads to improvement on the clinical features in 90.1% patients. No signiﬁcant
improvement in clinical features were noticed in 9.8% patients. None of the studied patients reported worse
clinical condition after treatment of allergic rhinitis. No mortality was recorded from allergic rhinitis in this
study.
Conclusion: Allergic rhinitis aﬀect all paediatric age group and there were delayed presentation in the partici-
pants. There were associated comorbid illnesses, complications and aﬀectation of quality of life at presentation
in majority of the patients.
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1. Introduction
Allergic rhinitis happens when aeroallergens trigger the release of
histamine in the nose and it results from nasal congestion, rhinorrhea,
sneezing and itching. Symptoms in the eyes, ears and throat are fre-
quently associated [1–5].
Majority of the available data in the literature has focused on adults
with allergic rhinitis and very little data is available about prevalence,
burden, quality of life, complications, eﬀects and comorbidities in
children especially in developing countries [6]. In an American survey,
61% of children were diagnosed with allergic rhinitis by 6 years of age,
and most of these children were diagnosed by pediatricians [7–11].
Allergic rhinitis was previously classiﬁed as seasonal and/or perennial.
New Allergic Rhinitis and Its Impact on Asthma (ARIA) classiﬁcation
system was designed to better classify the disorder and include the
categories of intermittent and persistent allergic rhinitis [12–16]. In
allergic rhinitis the allergens include house dust mites, grass pollen, tree
pollen, cockroaches, rodents, weed pollens, cat, dog, and molds
[17–21].Nonallergic triggers such as weather, fumes, odours, and ex-
ercise were commonly reported [15,16]. Allergic rhinitis may be due to
local IgE production in the nose if no allergen was identiﬁed [22–24].
The role of histamine in allergic diseases is well deﬁned [25–27]. His-
tamine mediates its eﬀects via an established set of histamine receptors.
In the nose this results in sneezing, itching and rhinorrhea. Risk factors
for pediatric allergic rhinitis include genetic predisposition, prenatal as
well as early-life environmental exposures (infections, indoor and out-
door air pollution, tobacco smoke, and diet) at a critical time when the
immune system is still undergoing development, atopy, high socio-
economic status, and positive family history [28,29].
Complications of allergic rhinitis include the following: acute or
chronic sinusitis, otitis media, sleep disturbance or apnea, dental pro-
blems (overbite). Morbidity/mortality from allergic rhinitis is not a life-
threatening unless it is accompanied by comorbid illnesses such as se-
vere asthma or anaphylaxis, eczema, and food allergies.
There is increase in prevalence rate of allergic rhinitis in recent
time. Despite this increment there is still paucity of literature on allergic
rhinitis in the developing countries. This study aimed at determining
prevalence, sociodemographic features, comorbid illnesses, complica-
tions and quality of life of patients with allergic rhinitis in the study
institution.
2. Materials and methods
This is a prospective hospital based study of the patients with
clinical diagnosis of allergic rhinitis in children seen, reviewed and
managed in the Ear, Nose and Throat department of the Ekiti State
University Teaching Hospital, Ado Ekiti, Nigeria. This included all
children aged 18 years and below at the time of this work. This tertiary
health institution is the only state ownedhealth facility serving over two
millions populations in the state and 4 neighboring states of Ondo,
Osun, Kogi and Kwara. The study was carried out over a period of two
years (from June 2015 to May 2017). All consecutive patients who
presented to the department were enrolled into the study. Informed
consent was obtained from patients/guardian/parents before patients
were enrolled into the study. Interviewer assisted questionnaire (pre-
tested) were given to consented patients/parents/guardians to obtain
detailed data on sociodemographic features of patients. Their detailed
otorhinolaryngological history including their past medical, surgical
and social history was also taken. Also history of allergens exposure and
drugs usage were taken.
All the patients that were recruited into this study had detailed ENT
examination done using endoscopes. Detailed nose, ear, throat, head
and neck examination were done and documented. Detailed rhinolo-
gical examination includes anterior rhinoscopy, nasal cavity and pos-
terior rhinoscopy with nasoendoscopy. Oropharyngeal examination
performed and ﬁndings were documented. General physical and
systemic examination was performed.
Limitations of this study include the absence of allergy testing and
failure of estimating the measure of quality of life based on a standar-
dized and validated (generic or disease-related) questionnaires.
Mucopurulent sino nasal discharge (specimen) was aseptically taken
examined and sent for microscopy, culture, and sensitivity in case of
any super imposed bacterial infection. Further investigations such as x
ray, computerized tomographic (CT) scan of the paranasal sinuses were
requested based on clinical ﬁndings.
All the patients were educated based on the ﬁndings on the line of
management of allergic rhinitis. Treatment modalities were avoidance
of allergens, antibiotic therapy (such as amoxicillin/clavulanic acid to
treat superimposed infection), antihistamines, topical corticosteroids,
systemic steroids and surgery (adenoidectomy with or without tonsil-
lectomy) depending on clinical ﬁndings. Participants were followed up
in the ear, nose and throat clinic for possible outcome and complica-
tions.
All data obtained were documented, collated and analysed. The data
analysis was done by using SPSS version 18. The analyzed data were
presented in simple descriptive tables and charts.
Ethical clearance was sought for and obtained from the ethical
committee of the hospital.
3. Results
A total of 4341 patients were seen in the ENT department over the
study period. There were 265 paediatric patients (characterised by
rhinorrhoea, nasal obstruction, epiphora, and nasal and eye itching)
enrolled into the study. Prevalence of allergic rhinitis in children in this
study was 6.1%. Allergic rhinitis aﬀects all the paediatric age group
with a peak at preschool age group (1–5) years accounted for 47.9%.
This was demonstrated in Fig. 1. There were 167 (63.0%) males 98
(37.0%) females with male to female ratio of 2:1. A total of 112 (42.3%)
participants were living in urban setting while 153 (57.7%) were from
rural setting. Majority (40.4%) of the patients were in nursery, 26.8%
were in secondary school level while 9.4% are in post-secondary level
of education. Parent's major occupation were mainly farming (27.2%),
teaching (25.9%) while 10.6% are health worker. This was illustrated in
Table 1.
There were positive family history of allergy in 145 (54.7%) while
120 (45.3%) did not have. From the patients history perennial allergic
rhinitis were noted in 169 (63.8%) patients while seasonal allergic
rhinitis were noted in 96 (36.2%) patients. Using ARIA classiﬁcation as
shown in Table 2, majority 145 (54.8%) of the patients were moderate-
Fig. 1. Age group(years) among patients.
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severe persistent allergic rhinitis and 51 (19.2%) had moderate-severe
intermittent allergic rhinitis. Major form of allergens was 217 (81.8%)
inhalant and the least form of allergen was 15 (5.7%) ingestant. In this
study, self-reported allergy were based on the trigger factors. The
commonest identiﬁed trigger factors among the study population were
as follows: dust, cold weather and smoke which were accounted for 158
(59.6%), 99 (37.4%) and 50 (18.9%) of the study patients respectively.
The less common trigger factors were soap and perfume which ac-
counted for 11(4.2%) and 3 (1.1%). This was showed in Table 2.
Major associated comorbid illnesses among patients with allergic
rhinitis in this study were tonsillar hypertrophy, adenoid hypertrophy
and inferior turbinate hypertrophy which accounted for 147 (55.5%),
123 (46.4%) and 107 (40.4%) respectively. Minor associated comorbid
illnesses in this study were sinusitis, allergic dermatitis and ear dis-
charge which accounted for 14 (5.3%), 14 (5.3%) and 22 (8.3%) re-
spectively. This was showed in Table 3.
Clinical presentation of allergic rhinitis in this study were mainly
nasal blockage in 201 (75.8%) of our patients, runny nose in 173
(65.3%) and 155 (58.5%) had recurrent sneezing. Permanent nasal
obstruction were noticed in 172 (64.9%) while recurrent nasal ob-
struction were noticed in 29 (10.9%). Trigger factors for sneezing were
identiﬁed in 146 (55.1%) patients. Less common presentation of
allergic rhinitis in this study were 86 (32.5%) itchy eye and 87 (32.8%)
itchy nose. This was illustrated in Table 4.
Clinical ﬁndings in this study were mainly oedematous nasal mu-
cosa, enlarged turbinate and reduced nasal patency and they accounted
for 193 (72.8%), 178 (67.2%) and 140 (52.8%) respectively.
Common complications which were associated with allergic rhinitis
includes pharyngitis in 93 (35.1%), otitis media in 85 (32.1%) while 75
(28.3%) has headache. Fig. 2.
Microscopic, culture and sensitivity were requested for patients with
mucopurulent discharge. There was no growth in 9 (3.4%) of the nasal
specimen taken. There were growths of streptococcus in 64 (24.2%),
Staphylococcus aureus in 49 (18.5%) and Hemophilus inﬂuenzae in 31
(11.7%) of the patients.
Treatment approach was by combination of allergens avoidance,
medical treatment and surgery was reserved for patients with adenoid
Table 1
Sociodemographic features of the patients.
Sociodemographic features Number Percentage (%)
Sex
Male 167 63.0
Female 98 37.0
Residential
Urban 112 42.3
Rural 153 57.7
Education level
Nursery 107 40.4
Primary 62 23.4
Secondary 71 26.8
Post secondary 25 9.4
Parental occupation
Business 55 20.8
Teaching 69 25.9
Industrial worker 41 15.5
Farming 72 27.2
Health worker 28 10.6
Table 2
Features of Allergy among the patients.
Features of Allergy Number Percentage (%)
Family history of Allergy
Present 145 54.7
Absent 120 45.3
Type of Allergy
Perennial 169 63.8
Seasonal 96 36.2
ARIA Classiﬁcation
Mild-Intermittent 26 9.8
Moderate-Severe intermittent 51 19.2
Mild-Persistent 43 16.2
Moderate-Severe Persistent 145 54.8
Form of Allergy
Inhalant 217 81.8
Ingestantt 15 5.7
Contactant 33 12.5
Trigger factor
Dust 158 59.6
Cold weather 99 37.4
Smoke 50 18.9
Perfume 11 4.2
Vehicle exhaust 24 9.1
Soap 3 1.1
Table 3
Comorbid illnesses among the patients.
Comorbid illnesses Number Percentage (%)
Asthma 63 23.8
Allergic conjunctivitis 84 31.7
Allergic dermatitis 14 5.3
Recurrent tonsillitis 147 55.5
Adenoid hypertrophy 123 46.4
Inferior turbinate hype 107 40.4
Nasal polyps 25 9.4
Ear discharge 22 8.3
Sinusitis 14 5.3
Table 4
Symptoms of allergy among the patients.
*Symptoms Number Percentage (%)
Blocked nose 201 75.8
Runny nose 173 65.3
Recurrent sneezing 155 58.5
Nasal itching 141 53.2
Itchy throat 103 38.9
Itchy ear 93 35.1
Watery eyes 88 33.2
Itchy nose 87 32.8
Eye itching 86 32.5
*NB.
*Some patients has more than one symptoms.
Fig. 2. Complications of allergic rhinitis.
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and/or tonsils hypertrophy. Treatment of allergic rhinitis and comorbid
illnesses leads to improvement and recovery on the clinical features
(not cure) in 239 (90.2%) patients. There was no signiﬁcant improve-
ment in clinical features in 26 (9.8%) of our patients. None of the
studied patients reported worse clinical condition after treatment of
allergic rhinitis and comorbid illnesses. No mortality was recorded from
allergic rhinitis, comorbid illnesses, complications or treatment inter-
vention in this study.
4. Discussion
Allergic rhinitis in children is still a global healthy problem with
little or no recognition. In most cases children allergic rhinitis is com-
monly under-diagnosed because the symptoms are frequently attributed
to a viral or recurrent ﬂu. As a result of this most parents do not seek
medical intervention. Some parents use available medication or local
herbs without doctors prescription and such symptoms treatment are
suboptimal [30].
Prevalence of allergic rhinitis in children in this study was 6.1% this
is lower than prevalence rate in other previous studies [7–9]. This low
prevalence of allergic rhinitis in children may be due to underestimate
as majority of patients with this condition are treated by their family
physician or paediatrician at peripheral hospitals. Majority of the pa-
tients in this study were with severe symptoms, complicated cases or
associated co-morbidities were referred to otorhinolaryngologist, head
and neck surgeon. A true prevalence of allergic rhinitis among pae-
diatric in this region requires comprehensive community-based study.
The study population were mainly civil servant from low industrial
state in a developing part of the world compared to study in developed
part of the world with higher prevalence of allergic rhinitis. There is
higher prevalence in some developing region such in African countries
includes 29.6% in Nigeria and 30% in Cape Town in South Africa
[31,32]. Factors responsible for high prevalence of allergic rhinitis in
children includes climatic factors, dietary changes, environmental fac-
tors and industrial pollution were very low in the study population.
In this study, male gender preponderance was observed which is in
agreement with other study [33]. This however diﬀers from other
studies with female preponderance [34]. There are some studies with
equal sex preponderance [35]. This gender proportions is found to be
inconsistent in diﬀerent study. Gender parity ﬁndings may likely be by
chance.
Majority of the paediatric patients in this study were preschool
children this is comparable with other previous studies [36,37]. This
may be due to increased number of associated comorbid illnesses such
as adenoid with tonsillar hypertrophy of allergic rhinitis at this age
group which prompted parent to attend specialist medical services in
this study. Allergic rhinitis is also associated with severe and trouble-
some symptoms which are exacerbated by acute viral infections forcing
parents or guardian to seek specialist medical cares. Common chronic
symptoms of allergic rhinitis are commonly ignored in older aged pa-
tients in this study except when complicated.
In this study environmental factors that were responsible for in-
crease risk of allergic rhinitis in children were dusts, fumes exhausts
from vehicle, environmental tobacco smoke exposure and moulds and
perfume and this is similar to ﬁndings in other studies [38–40]. Many
patients in this study had family history of allergy. Similar ﬁndings
were discovered in previous study [41].
Inﬂammation of the nasal mucosal lining and contiguous structure
from allergens results in sneezing, rhinorrhoea, nasal congestion, with
itching of the nose, ear, palate, throat and eyes [42]. Nasal obstruction
usually worsen with comorbid inferior turbinate hypertrophy, nasal
polyps and adenoid hypertrophy among our patients. Blocked nose
showed signiﬁcant association with adenoid hypertrophy in children in
this study. Rhinorrhea is the resultant eﬀects of nasal mucosal goblet
cell stimulation by the allergens. In our study, high percentage of pa-
tients had runny nose (rhinorrhoea), nasal blockage, bout of sneezing
and these ﬁndings are similar to other studies on allergic rhinitis [43].
Consequently qualities of life are grossly aﬀected in some of our pa-
tients. Qualities of life that are often aﬀected include impaired social
life (especially in the older ones), sleep disruption, daytime sleepiness,
absenteeism and irritability [43]. Nasal obstruction and nasal conges-
tion were responsible for the sleep disturbances [43]. Nasal blockage
and rhinorrhoea when severe may cause interference with daily activ-
ities and embarrassment to allergic rhinitis patients [44].
In this study population, allergic rhinitis in children has signiﬁcant
comorbid illnesses such as asthma, sinusitis, otitis media, adenoid hy-
pertrophy and allergic conjunctivitis in diﬀerent percentages. Many
other studies reported diﬀerent percentage of associated comorbid ill-
nesses [30].
In the management of the patients with allergic rhinitis in children
in this study multidisciplinary approach was used. This is because of the
associated comorbid illnesses and complication with allergic rhinitis in
the studied children. The health team included general practitioner,
paediatricians, allergists and otorhinolaryngologists, head and neck
surgeon [30]. The treatment of approach were allergen avoidance,
medical intervention and surgical treatment of comorbid illnesses and
complications. Allergens control requires aggressive environmental
control which is eﬀective [45]. Medical treatment includes intranasal
steroid, antihistamines and antibiotics to treat superimposed infection
and depending on the presenting clinical features. Surgical therapy was
reserved for adequate treatment of comorbid illnesses, complications
and refractory to medical treatment [46,47]. Surgical treatments are for
patients with adenoid hypertrophy, tonsillar hypertrophy and turbinate
hypertrophy. Other form treatments such as Immunotherapy, desensi-
tization are not used in this study due to available facilities in the study
[48]. Montelukast a leukotriene receptor antagonist used for the
maintenance treatment of allergy and asthma is not available in our
center.
There was no associated mortality to allergic rhinitis in children in
our study. Common cause of death due to comorbid illnesses, surgical
complications were recorded in other study [49].
Findings in this study was due to some potential limiting factors
which includes to performed allergy testing, hospital based study and
measurement of quality of life without the use of standardized and
validated (generic or disease-related) questionnaires. Despite these
limitations this study provide hospital information which can serve as
bases for community based study and may help health care workers to
develop guideline in management of allergic rhinitis in children.
5. Conclusion
Allergic rhinitis is very common and aﬀect all paediatric age group
usually neglected and delayed presentation in the participants.
Prevalence of allergic rhinitis was low in this study compare to previous
study. There were associated comorbid illnesses, complications and
aﬀectation of quality of life before presentation to the otorhinolar-
yngologist in majority of the patients. Early referral is highly re-
commended to the specialist to avoid on toward eﬀect.
Conﬂicts of interest
None.
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